Published in Science · View the paper (DOI)
A single monoclonal antibody isolated from an Ebola survivor protected non-human primates even after lethal infection, offering hope for a potential treatment. The findings suggest a novel site of vulnerability on the Ebola virus and may lead to effective therapy.
Coverage from 3 institutions
- Experimental Ebola antibody protects monkeys NIH/National Institute of Allergy and Infectious Diseases · Feb 25, 2016 · first to report
- Single antibody from human survivor protects nonhuman primates against Ebola virus US Army Medical Research Institute of Infectious Diseases · Feb 25, 2016
- Antibodies eliminate Ebola symptoms 5 days after infection American Association for the Advancement of Science (AAAS) · Feb 25, 2016